LOVFF (Cannara Biotech) Interest Expense : $-2.81 Mil (TTM As of Aug. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cannara Biotech's interest expense for the three months ended in Aug. 2024 was $ -0.20 Mil. Its interest expense for the trailing twelve months (TTM) ended in Aug. 2024 was $-2.81 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cannara Biotech's Operating Income for the three months ended in Aug. 2024 was $ 3.70 Mil. Cannara Biotech's Interest Expense for the three months ended in Aug. 2024 was $ -0.20 Mil. Cannara Biotech's Interest Coverage for the quarter that ended in Aug. 2024 was 18.57. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cannara Biotech Interest Expense Historical Data

The historical data trend for Cannara Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Interest Expense Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Interest Expense

Get a 7-Day Free Trial

-1.00

-1.24

-1.68

-2.88

-3.17

Cannara Biotech Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Interest Expense	Get a 7-Day Free Trial															-0.25	-0.77	-0.80	-1.04	-0.20

Cannara Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.81 Mil.

Cannara Biotech (OTCPK:LOVFF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cannara Biotech's Interest Expense for the three months ended in Aug. 2024 was $-0.20 Mil. Its Operating Income for the three months ended in Aug. 2024 was $3.70 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Aug. 2024 was $28.43 Mil.

Cannara Biotech's Interest Coverage for the quarter that ended in Aug. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Aug. 2024 )	/	Interest Expense (Q: Aug. 2024 )
	=	-1	*	3.695	/	-0.199
	=	18.57

The higher the ratio, the stronger the company's financial strength is.

Cannara Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (OTCPK:LOVFF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

8CB0:Germany LOVE:Canada

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .